Extranodal involvement: a significant predictor of outcome for patients with non-Hodgkin lymphoma having remained disease at autologous stem cell transplantation

被引：0
|
作者：
Ko, OB [1 ]
Kim, S [1 ]
Kim, HJ [1 ]
Park, J [1 ]
Kim, SW [1 ]
Kim, SB [1 ]
Kang, YK [1 ]
Lee, J [1 ]
Kim, W [1 ]
Huh, J [1 ]
Suh, C [1 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S241 / S241
页数：1
相关论文
共 50 条
  • [1] Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: Complications and outcome
    Kumar, Lalit
    Ganessan, Prasanth
    Ghosh, Indraneel
    Panda, Deepanjan
    Gogia, Ajay
    Mandhania, Sushil
    NATIONAL MEDICAL JOURNAL OF INDIA, 2010, 23 (06): : 330 - 335
  • [2] Autologous stem cell transplantation in patients with non-Hodgkin's lymphoma
    Prinz, E
    Mitterbauer, M
    Keil, F
    Kalhs, P
    Mitterbauer, G
    Höcker, P
    Jäger, U
    Chott, A
    Mannhalter, C
    Greinix, H
    BONE MARROW TRANSPLANTATION, 2001, 27 : S272 - S272
  • [3] OUTCOME OF PATIENTS WITH TRANSFORMED INDOLENT NON-HODGKIN LYMPHOMA REFERRED FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
    Villa, D.
    Crump, M.
    Keating, A.
    Ambler, K.
    Kuruvilla, J.
    ANNALS OF ONCOLOGY, 2011, 22 : 188 - 189
  • [4] Comorbidity at Relapse Is An Independent Predictor for Eligibility and Outcome of Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin Lymphoma
    Plattel, Wouter J.
    Kluin-Nelemans, Hanneke C.
    de Bock, Geertruida H.
    van Imhoff, Gustaaf
    BLOOD, 2009, 114 (22) : 914 - 914
  • [5] Allogeneic or autologous haematopoietic stem cell transplantation for non-Hodgkin lymphoma: status at transplantation and outcome
    Ferrant, A
    Van den Neste, E
    Michaux, L
    Durbecq, J
    Latinne, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S36 - S36
  • [6] Outcome of autologous stem-cell transplantation in Hodgkin and non hodgkin lymphoma patients
    Soyer, N.
    Mutlu, C. Atmaca
    Vural, F.
    Tombuloglu, M.
    Tobu, M.
    Sahin, F.
    Saydam, G.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S289 - S290
  • [7] Rituximab: Enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma
    Gisselbrecht, C
    Mounier, N
    SEMINARS IN ONCOLOGY, 2003, 30 (01) : 28 - 33
  • [8] Autologous stem cell transplantation in patients with aggressive non-Hodgkin's lymphoma
    Minigo, H
    Vrhovac, R
    Planinc-Peraica, A
    Ostojic-Kolonic, S
    Radic-Kristo, D
    Maric-Besic, K
    Maglov, C
    Strauss-Patko, M
    Siftar, Z
    Kardum, M
    Kardum-Skelin, I
    Sustercic, D
    Dominis, M
    Kusec, R
    Jaksic, B
    BONE MARROW TRANSPLANTATION, 2001, 27 : S266 - S266
  • [9] Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation
    Villa, D.
    Crump, M.
    Keating, A.
    Panzarella, T.
    Feng, B.
    Kuruvilla, J.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1603 - 1609
  • [10] The Outcome of Autologous Hematopoietic Cell Transplantation in Elderly Patients with Aggressive Non-Hodgkin Lymphoma
    Osmanilhan
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Toprak, Selami kocak
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Gurman, Gunhan
    Beksac, Meral
    BLOOD, 2021, 138
12345